197 related articles for article (PubMed ID: 22652784)
1. Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity.
Shen C; Zhao CY; Zhang R; Qiao L
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2356-70. PubMed ID: 22652784
[TBL] [Abstract][Full Text] [Related]
2. Obesity-associated mechanisms of hepatocarcinogenesis.
Karagozian R; Derdák Z; Baffy G
Metabolism; 2014 May; 63(5):607-17. PubMed ID: 24629562
[TBL] [Abstract][Full Text] [Related]
3. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
Rajesh Y; Sarkar D
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
[TBL] [Abstract][Full Text] [Related]
4. Obesity and hepatocellular carcinoma.
Caldwell SH; Crespo DM; Kang HS; Al-Osaimi AM
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S97-103. PubMed ID: 15508109
[TBL] [Abstract][Full Text] [Related]
5. Obesity, adipokines and hepatocellular carcinoma.
Duan XF; Tang P; Li Q; Yu ZT
Int J Cancer; 2013 Oct; 133(8):1776-83. PubMed ID: 23404222
[TBL] [Abstract][Full Text] [Related]
6. Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back.
Yilmaz Y; Colak Y; Kurt R; Senates E; Eren F
Tumori; 2013; 99(1):10-6. PubMed ID: 23548993
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
8. Why should the gastroenterologist bother about obesity? An oncologic point of view.
Charette N; Leclercq IA
Acta Gastroenterol Belg; 2010; 73(4):504-9. PubMed ID: 21299162
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
Starley BQ; Calcagno CJ; Harrison SA
Hepatology; 2010 May; 51(5):1820-32. PubMed ID: 20432259
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Massoud O; Charlton M
Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
[TBL] [Abstract][Full Text] [Related]
11. Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis.
Shimizu M; Tanaka T; Moriwaki H
Semin Immunopathol; 2013 Mar; 35(2):191-202. PubMed ID: 22945457
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
Noureddin M; Rinella ME
Clin Liver Dis; 2015 May; 19(2):361-79. PubMed ID: 25921668
[TBL] [Abstract][Full Text] [Related]
13. [Role of environmental factors in the etiology of hepatocellular carcinoma].
Tornai I
Orv Hetil; 2010 Jul; 151(28):1132-6. PubMed ID: 20570793
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P; Romeo S; Valenti L
World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
[TBL] [Abstract][Full Text] [Related]
15. Obesity, insulin resistance, NASH and hepatocellular carcinoma.
Yu J; Shen J; Sun TT; Zhang X; Wong N
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):483-91. PubMed ID: 23876851
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
Torres DM; Harrison SA
Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
[TBL] [Abstract][Full Text] [Related]
17. HCC and NASH: how strong is the clinical demonstration?
Rosmorduc O; Fartoux L
Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):202-8. PubMed ID: 22326764
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we.
Tsoulfas G
World J Gastroenterol; 2019 Aug; 25(29):3842-3848. PubMed ID: 31413522
[TBL] [Abstract][Full Text] [Related]
19. Role of adipokines in complications related to obesity: a review.
Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K
Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.
Chettouh H; Lequoy M; Fartoux L; Vigouroux C; Desbois-Mouthon C
Liver Int; 2015 Oct; 35(10):2203-17. PubMed ID: 26123841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
